keyword
https://read.qxmd.com/read/38595695/glucometabolic-related-genes-as-diagnostic-biomarkers-and-therapeutic-targets-for-alzheimer-s-disease-and-type-2-diabetes-mellitus-a-bioinformatics-analysis
#21
JOURNAL ARTICLE
Shuo Liu, He Chen, Xiao-Dong He, Xiao-Ou Yang
BACKGROUND: Alzheimer's disease (AD) and type 2 diabetes mellitus (T2DM) are two widespread chronic disorders characterized by shared risk factors and molecular pathways. Glucose metabolism, pivotal for cellular homeostasis and energy supply, plays a critical role in these diseases. Its disturbance has been linked to the pathogenesis of both AD and T2DM. However, a comprehensive investigation into the specific roles of glucometabolic genes in the onset and progression of AD and T2DM has yet to be conducted...
2024: Neurology Research International
https://read.qxmd.com/read/38593823/association-between-triglyceride-glucose-index-with-cognitive-impairment-and-dementia-in-adult-population-a-meta-analysis
#22
JOURNAL ARTICLE
Yuqing Han, Xu Meng, Dahui Wang
The current understanding of the correlation between insulin resistance (IR) and cognitive dysfunction is limited. Therefore, the objective of this systematic review and meta-analysis was to assess the association between the triglyceride glucose (TyG) index, a recently suggested indicator of IR, and cognitive impairment and dementia in the adult population. Observational studies pertinent to our research were identified through comprehensive searches of the PubMed, Embase, and Web of Science databases. To account for potential heterogeneity, the random-effects models were employed to aggregate the findings...
April 9, 2024: Hormone and Metabolic Research
https://read.qxmd.com/read/38592845/-withania-somnifera-l-dunal-a-potential-source-of-phytochemicals-for-treating-neurodegenerative-diseases-a-systematic-review
#23
REVIEW
Valentina Lerose, Maria Ponticelli, Nadia Benedetto, Vittorio Carlucci, Ludovica Lela, Nikolay T Tzvetkov, Luigi Milella
Withania somnifera (L.) Dunal is a medicinal plant belonging to the traditional Indian medical system, showing various therapeutic effects such as anti-cancer, anti-inflammatory, anti-microbial, anti-diabetic, and hepatoprotective activity. Of great interest is W. somnifera 's potential beneficial effect against neurodegenerative diseases, since the authorized medicinal treatments can only delay disease progression and provide symptomatic relief and are not without side effects. A systematic search of PubMed and Scopus databases was performed to identify preclinical and clinical studies focusing on the applications of W...
March 8, 2024: Plants (Basel, Switzerland)
https://read.qxmd.com/read/38591622/understanding-exosomes-part-2-emerging-leaders-in-regenerative-medicine
#24
REVIEW
Richard J Miron, Nathan E Estrin, Anton Sculean, Yufeng Zhang
Exosomes are the smallest subset of extracellular signaling vesicles secreted by most cells with the ability to communicate with other tissues and cell types over long distances. Their use in regenerative medicine has gained tremendous momentum recently due to their ability to be utilized as therapeutic options for a wide array of diseases/conditions. Over 5000 publications are currently being published yearly on this topic, and this number is only expected to dramatically increase as novel therapeutic strategies continue to be developed...
April 9, 2024: Periodontology 2000
https://read.qxmd.com/read/38590305/emerging-significance-of-butyrylcholinesterase
#25
REVIEW
Gumpeny R Sridhar, Lakshmi Gumpeny
Butyrylcholinesterase (BChE; EC 3.1.1.8), an enzyme structurally related to acetylcholinesterase, is widely distributed in the human body. It plays a role in the detoxification of chemicals such as succinylcholine, a muscle relaxant used in anesthetic practice. BChE is well-known due to variant forms of the enzyme with little or no hydrolytic activity which exist in some endogamous communities and result in prolonged apnea following the administration of succinylcholine. Its other functions include the ability to hydrolyze acetylcholine, the cholinergic neurotransmitter in the brain, when its primary hydrolytic enzyme, acetylcholinesterase, is absent...
March 20, 2024: World Journal of Experimental Medicine
https://read.qxmd.com/read/38585783/screening-carbon-nano-materials-for-preventing-amyloid-protein-aggregation-by-adopting-a-facile-method
#26
Daisy L Wilson, Ana Carreon, Sampath Chinnam, Hamidreza Sharifan, Jyoti Ahlawat, Mahesh Narayan
The soluble-to-toxic transformation of intrinsically disordered amyloidogenic proteins such as amyloid beta (Aβ), α-synuclein, mutant Huntingtin Protein (mHTT) and islet amyloid polypeptide (IAPP) among others is associated with disorders such as Alzheimer's disease (AD), Parkinson's disease (PD), Huntington's disease (HD) and Type 2 Diabetes (T2D), respectively. The dissolution of mature fibrils and toxic amyloidogenic intermediates including oligomers continues to be the pinnacle in the treatment of neurodegenerative disorders...
March 29, 2024: Research Square
https://read.qxmd.com/read/38577975/anorexigenic-neuropeptides-as-anti-obesity-and-neuroprotective-agents
#27
JOURNAL ARTICLE
Veronika Strnadová, Andrea Pačesová, Vilém Charvát, Zuzana Šmotková, Blanka Zelezna, Jaroslav Kunes, Lenka Maletinska
Since 1975, the incidence of obesity has increased to epidemic proportions, and the number of patients with obesity has quadrupled. Obesity is a major risk factor for developing other serious diseases, such as type 2 diabetes mellitus, hypertension, and cardiovascular diseases. Recent epidemiologic studies have defined obesity as a risk factor for the development of neurodegenerative diseases, such as Alzheimer's disease (AD) and other types of dementia. Despite all these serious comorbidities associated with obesity, there is still a lack of effective antiobesity treatment...
April 5, 2024: Bioscience Reports
https://read.qxmd.com/read/38576104/identification-of-risk-factors-for-gliptin-associated-bullous-pemphigoid-among-diabetic-patients
#28
JOURNAL ARTICLE
Dana Shalmon, Efrat Bar-Ilan, Alon Peled, Shamir Geller, Jonathan Bar, Naama Schwartz, Eli Sprecher, Mor Pavlovsky
Drug-associated bullous pemphigoid has been shown to follow long-term gliptin (dipeptidyl-peptidase 4 inhibitors) intake. This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary centre among diabetic patients exposed to gliptins between the years 2008-2021. Data including demographics, comorbidities, medications, and laboratory results were collected using the MDClone platform. Seventy-six patients with type 2 diabetes treated with dipeptidyl-peptidase 4 inhibitors who subsequently developed bullous pemphigoid were compared with a cohort of 8,060 diabetic patients exposed to dipeptidyl-peptidase 4 inhibitors who did not develop bullous pemphigoid...
April 4, 2024: Acta Dermato-venereologica
https://read.qxmd.com/read/38571914/fish-a-scoping-review-for-nordic-nutrition-recommendations-2023
#29
REVIEW
Johanna E Torfadottir, Stine M Ulven
The aim of this scoping review was to conduct evidence-based documentation between fish intake and health outcomes for food-based dietary guidelines (FBDGs) in the Nordic Nutrition Recommendations (NNR) 2023. For most health outcomes, the evidence for fish oil and n-3 long chain (LC) polyunsaturated fatty acids (PUFA) supplementation was included when examining evidence between fish intake and health. In this review, conclusions from qualified systematic reviews (qSR) approved by NNR2023 are included. In addition, conclusions of a de novo systematic reviews on the topic of n-3 LC-PUFA, asthma, and allergy are included...
2024: Food & Nutrition Research
https://read.qxmd.com/read/38569140/associations-between-age-at-menopause-vascular-risk-and-3-year-cognitive-change-in-the-canadian-longitudinal-study-on-aging
#30
JOURNAL ARTICLE
Madeline Wood Alexander, Che-Yuan Wu, Gillian T Coughlan, Tanvi Puri, Rachel F Buckley, Priya Palta, Walter Swardfager, Mario Masellis, Liisa A M Galea, Gillian Einstein, Sandra E Black, Jennifer S Rabin
BACKGROUND AND OBJECTIVES: Mounting evidence supports sex differences in Alzheimer disease (AD) risk. Vascular and hormonal factors may together contribute to AD risk in female adults. We investigated whether age at menopause, vascular risk, and history of hormone therapy (HT) containing estrogens together influence cognition over a 3-year follow-up period. We hypothesized that earlier menopause and elevated vascular risk would have a synergistic association with lower cognitive scores at follow-up and that HT containing estrogens would attenuate this synergistic association to preserve cognition...
May 2024: Neurology
https://read.qxmd.com/read/38569027/csf-biomarkers-of-immune-activation-and-alzheimer-s-disease-for-predicting-cognitive-impairment-risk-in-the-elderly
#31
JOURNAL ARTICLE
Francis Shue, Launia J White, Rachel Hendrix, Jason Ulrich, Rachel L Henson, William Knight, Yuka A Martens, Ni Wang, Bhaskar Roy, Skylar C Starling, Yingxue Ren, Chengjie Xiong, Yan W Asmann, Jeremy A Syrjanen, Maria Vassilaki, Michelle M Mielke, Jigyasha Timsina, Yun Ju Sung, Carlos Cruchaga, David M Holtzman, Guojun Bu, Ronald C Petersen, Michael G Heckman, Takahisa Kanekiyo
The immune system substantially influences age-related cognitive decline and Alzheimer's disease (AD) progression, affected by genetic and environmental factors. In a Mayo Clinic Study of Aging cohort, we examined how risk factors like APOE genotype, age, and sex affect inflammatory molecules and AD biomarkers in cerebrospinal fluid (CSF). Among cognitively unimpaired individuals over 65 ( N = 298), we measured 365 CSF inflammatory molecules, finding age, sex, and diabetes status predominantly influencing their levels...
April 5, 2024: Science Advances
https://read.qxmd.com/read/38567612/potential-acetylcholinesterase-inhibitors-to-treat-alzheimer-s-disease
#32
JOURNAL ARTICLE
A Saud, V Krishnaraju, A Taha, K Kalpana, V Malarkodi, S Durgaramani, V Vinoth Prabhu, F A Saleh, S Ezhilarasan
OBJECTIVE: Alzheimer's disease (AD) is identified by neuropathological symptoms, and there is now no effective treatment for the condition. A lack of the brain neurotransmitter acetylcholine has been related to the etiology of Alzheimer's disease. Acetylcholinesterase is an enzyme that breaks down acetylcholine to an inactive form and causes the death of cholinergic neurons. Conventional treatments were used but had less effectiveness. Therefore, there is a crucial need to identify alternative compounds with potential anti-cholinesterase agents and minimal undesirable effects...
March 2024: European Review for Medical and Pharmacological Sciences
https://read.qxmd.com/read/38566440/association-between-hypothalamic-alzheimer-s-disease-pathology-and-body-mass-index-the-hisayama-study
#33
JOURNAL ARTICLE
Kaoru Yagita, Hiroyuki Honda, Tomoyuki Ohara, Sachiko Koyama, Hideko Noguchi, Yoshinao Oda, Ryo Yamasaki, Noriko Isobe, Toshiharu Ninomiya
The hypothalamus is the region of the brain that integrates the neuroendocrine system and whole-body metabolism. Patients with Alzheimer's disease (AD) have been reported to exhibit pathological changes in the hypothalamus, such as neurofibrillary tangles (NFTs) and amyloid plaques (APs). However, few studies have investigated whether hypothalamic AD pathology is associated with clinical factors. We investigated the association between AD-related pathological changes in the hypothalamus and clinical pictures using autopsied brain samples obtained from deceased residents of a Japanese community...
April 2, 2024: Neuropathology: Official Journal of the Japanese Society of Neuropathology
https://read.qxmd.com/read/38565895/central-inhibition-of-stearoyl-coa-desaturase-has-minimal-effects-on-the-peripheral-metabolic-symptoms-of-the-3xtg-alzheimer-s-disease-mouse-model
#34
JOURNAL ARTICLE
Laura K Hamilton, Paule E H M'Bra, Sophia Mailloux, Manon Galoppin, Anne Aumont, Karl J L Fernandes
Evidence from genetic and epidemiological studies point to lipid metabolism defects in both the brain and periphery being at the core of Alzheimer's disease (AD) pathogenesis. Previously, we reported that central inhibition of the rate-limiting enzyme in monounsaturated fatty acid synthesis, stearoyl-CoA desaturase (SCD), improves brain structure and function in the 3xTg mouse model of AD (3xTg-AD). Here, we tested whether these beneficial central effects involve recovery of peripheral metabolic defects, such as fat accumulation and glucose and insulin handling...
April 2, 2024: Scientific Reports
https://read.qxmd.com/read/38562749/assessing-the-seasonality-of-lab-tests-among-patients-with-alzheimer-s-disease-and-related-dementias-in-oneflorida-data-trust
#35
Wenshan Han, Balu Bhasuran, Victorine Patricia Muse, Søren Brunak, Lifeng Lin, Karim Hanna, Yu Huang, Jiang Bian, Zhe He
About 1 in 9 older adults over 65 has Alzheimer's disease (AD), many of whom also have multiple other chronic conditions such as hypertension and diabetes, necessitating careful monitoring through laboratory tests. Understanding the patterns of laboratory tests in this population aids our understanding and management of these chronic conditions along with AD. In this study, we used an unimodal cosinor model to assess the seasonality of lab tests using electronic health record (EHR) data from 34,303 AD patients from the OneFlorida+ Clinical Research Consortium...
March 19, 2024: medRxiv
https://read.qxmd.com/read/38562743/microbial-determinants-of-dementia-risk-in-subjects-of-mexican-descent-with-type-2-diabetes-living-in-south-texas
#36
Lisa M Matz, Nisarg S Shah, Laura Porterfield, Olivia M Stuyck, Michael D Jochum, Rakez Kayed, Giulio Taglialatela, Randall J Urban, Shelly A Buffington
Type 2 diabetes (T2D) is a common forerunner of neurodegeneration and dementia, including Alzheimer's Disease (AD), yet the underlying mechanisms remain unresolved. Individuals of Mexican descent living in South Texas have increased prevalence of comorbid T2D and early onset AD, despite low incidence of the predisposing APOE-e4 variant and an absence of the phenotype among relatives residing in Mexico - suggesting a role for environmental factors in coincident T2D and AD susceptibility. Here, in a small clinical trial, we show dysbiosis of the human gut microbiome could contribute to neuroinflammation and risk for AD in this population...
March 22, 2024: medRxiv
https://read.qxmd.com/read/38562486/uplc-esi-ms-ms-based-widely-targeted-metabolomics-reveals-differences-in-metabolite-composition-among-four-ganoderma-species
#37
JOURNAL ARTICLE
Liu Wei-Ye, Guo Hong-Bo, Yang Rui-Heng, Xu Ai-Guo, Zhao Jia-Chen, Yang Zhao-Qian, Han Wen-Jun, Yu Xiao-Dan
The Chinese name "Lingzhi" refers to Ganoderma genus, which are increasingly used in the food and medical industries. Ganoderma species are often used interchangeably since the differences in their composition are not known. To find compositional metabolite differences among Ganoderma species, we conducted a widely targeted metabolomics analysis of four commonly used edible and medicinal Ganoderma species based on ultra performance liquid chromatography-electrospray ionization-tandem mass spectrometry. Through pairwise comparisons, we identified 575-764 significant differential metabolites among the species, most of which exhibited large fold differences...
2024: Frontiers in Nutrition
https://read.qxmd.com/read/38561470/exploring-bi-carbazole-linked-triazoles-as-inhibitors-of-prolyl-endo-peptidase-via-integrated-in-vitro-and-in-silico-study
#38
JOURNAL ARTICLE
Saeed Ullah, Farheen Mansoor, Salman Ali Khan, Uzma Jabeen, Amany I Almars, Hailah M Almohaimeed, Ahmed M Basri, Fahad M Alshabrmi
A serine protease called prolyl endopeptidase (PEP) hydrolyses the peptide bonds on the carboxy side of the proline ring. The excessive PEP expression in brain results in neurodegenerative illnesses like dementia, Alzheimer's disease, and Parkinson's disease. Results of the prior studies on antioxidant activity, and the non-cytotoxic effect of bi-carbazole-linked triazoles, encouraged us to extend our studies towards its anti-diabetic potential. Hence, for this purpose all compounds 1-9 were evaluated to reveal their anti-prolyl endo peptidase activity...
April 1, 2024: Scientific Reports
https://read.qxmd.com/read/38558823/polyphenols-immunonutrients-tipping-the-balance-of-immunometabolism-in-chronic-diseases
#39
REVIEW
Carolina Ferreira, Pedro Vieira, Helena Sá, João Malva, Miguel Castelo-Branco, Flávio Reis, Sofia Viana
Mounting evidence progressively appreciates the vital interplay between immunity and metabolism in a wide array of immunometabolic chronic disorders, both autoimmune and non-autoimmune mediated. The immune system regulates the functioning of cellular metabolism within organs like the brain, pancreas and/or adipose tissue by sensing and adapting to fluctuations in the microenvironment's nutrients, thereby reshaping metabolic pathways that greatly impact a pro- or anti-inflammatory immunophenotype. While it is agreed that the immune system relies on an adequate nutritional status to function properly, we are only just starting to understand how the supply of single or combined nutrients, all of them termed immunonutrients, can steer immune cells towards a less inflamed, tolerogenic immunophenotype...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38558059/the-associations-between-type-2-diabetes-and-plasma-biomarkers-of-alzheimer-s-disease-in-the-health-and-aging-brain-study-health-disparities-habs-hd
#40
JOURNAL ARTICLE
Fang Yu, Keenan A Pituch, Molly Maxfield, Elsa Baena, Yonas E Geda, Jeremy J Pruzin, David W Coon, Gabriel Q Shaibi
Alzheimer's disease (AD) affects Latinos disproportionately. One of the reasons underlying this disparity may be type 2 diabetes (T2D) that is a risk factor for AD. The purpose of this study was to examine the associations of T2D and AD blood biomarkers and the differences in these associations between Mexican Americans and non-Hispanic Whites. This study was a secondary analysis of baseline data from the observational Health and Aging Brain Study: Health Disparities (HABS-HD) that investigated factors underlying health disparities in AD in Mexican Americans in comparison to non-Hispanic Whites...
2024: PloS One
keyword
keyword
170576
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.